
Articles
-
2 weeks ago |
kiplinger.com | James Glassman
When it comes to inflation, the U.S. has been living in a fool’s paradise. Inflation — that is, the rise in the general level of prices — has been a fact of economic life, averaging 3.3% annually since 1914. But from 2009 to 2020, the consumer price index rose just 2.1% a year. We got used to inflation one-third lower than the historical norm, which is why post-COVID prices have been such a shock. The best way to drive inflation out of the system is to hike short-term interest rates.
-
2 weeks ago |
houstoniamag.com | James Glassman
Image: Courtesy James Glassman Every month in Houstonia, James Glassman, a.k.a the Houstorian, sheds light on a piece of the city’s history. Right around the time Houston’s live oaks began shedding their old leaves, the Houston Astros reported for spring training. While the baseball preseason action was in Florida, plenty of Houston fans shed their own winter wear and dusted off their Astros jerseys in anticipation of Opening Day.
-
3 weeks ago |
cryptostudent.io | Matthew Boyse |James Glassman
[[{„value”:”As the U.S. tries to make headway on a plan to end the war in Ukraine, European allies are moving to defend the country—and their continent—from Russia in the future. Discussions indicate that a coalition of the willing could provide a “presence on the ground, in the air, and at sea, as well as air defense.” This support is not set in stone. Right now, however, there’s a way Europe can show it’s serious: intensify its economic sanctions against Russia.
-
3 weeks ago |
fortune.com | Matthew Boyse |James Glassman
BYMatthew Boyse and James K. GlassmanMatthew Boyse, a former senior foreign service officer, is a senior fellow with the Hudson Institute’s Center on Europe and Eurasia. James K. Glassman, a former U.S. Under Secretary of State, is an advisor to Ukrainian businesses and nonprofits.
-
1 month ago |
detroitnews.com | James Glassman
James GlassmanThe Detroit NewsView Comments The government reported late last year that under a federal subsidy program called 340B, at least 55,000 hospitals, clinics and other “covered entities” paid $66 billion for pharmaceuticals in 2023. That’s an increase of 23% in a year and 1,220% since 2010 for a runaway program few Americans have heard of. Now, 340B is about to double or triple because of a misguided court ruling.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →